Press Resease

Neurorehabilitation Devices Market by Product Type (Neuro-Robotic Devices, Non-Invasive Stimulators, Wearable Devices, and Brain-Computer Interface), by Application (Parkinson’s Disease, Brain Trauma Injury, Spinal Cord Injury, Stroke, Schizophrenia, Cerebral Palsy, and Others), and by End-User (Hospitals/Clinics, Cognitive Care Centers, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Published Date: 23-Nov-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3550 Status : Published

Global neurorehabilitation devices market expected to generate revenue of around USD 3.2 billion by end of 2024, growing at a CAGR of around 15.3% between 2018 and 2024. Global neurorehabilitation devices market is increasing the prevalence of neurological disorders worldwide.

Description

The report covers forecast and analysis for the neurorehabilitation devices market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based revenue (USD Billion). The study includes drivers and restraints for the Neurorehabilitation devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the neurorehabilitation devices market on a global level.

In order to give the users of this report a comprehensive view on the neurorehabilitation devices market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, where the product, mode of purchase, application, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Neurorehabilitation Devices Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the neurorehabilitation devices market by segmenting the market based on product type, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on product type, the neurorehabilitation devices market is segmented into neuro-robotic devices, wearable devices, non-invasive stimulators, and brain-computer interface. Based on application, the neurorehabilitation devices market has been segmented into Parkinson’s disease, spinal cord injury, brain trauma injury, stroke, cerebral palsy, schizophrenia, and others. Based on end-user, the neurorehabilitation devices market is segmented into hospitals/clinics, cognitive care centers, research institutes, and others. 

Growing prevalence of neurological disorders increased elderly population, and technological breakthroughs in the neurorehabilitation devices are the major driving factors of neurorehabilitation devices market. The lack of ease associated with the usage of these devices, shortage of personalized home care neurorehabilitation devices, and insufficient disposable income witnessed across the developing countries might hinder the market growth during the forecast period.

The regional segmentation includes the current and forecasts demand North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with it further segmented into major countries including the U.S., Germany, Italy, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for fertility test market based on individual segments and applications in all the regions and countries.

The report also includes detailed profiles of various end players, such as Bionik Labs, Bioxtreme, Denecor, Ectron Ltd., Ekso Bionics, Helius Medical Technologies, Hocoma AG, MagVenture A/S, Medtronic, Neuro Style, Rehab-Robotics Company Limited, Rehabtronics Inc., St. Jude Medical Inc., and Tyromotion, among others.

This report segments the global neurorehabilitation devices market as follows:

Global Neurorehabilitation Devices Market: By Product Type

  • Neuro-Robotic Devices
  • Wearable Devices
  • Non-Invasive Stimulators
  • Brain-Computer Interface

Global Neurorehabilitation Devices Market: By Application

  • Parkinson’s Disease
  • Spinal Cord Injury
  • Brain Trauma Injury
  • Stroke
  • Cerebral Palsy
  • Schizophrenia
  • Others

Global Neurorehabilitation Devices Market: By End-User

  • Hospitals/Clinics
  • Cognitive Care Centers
  • Research Institutes
  • Others

Global Neurorehabilitation Devices Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Neurorehabilitation Devices Market, 2017 - 2024 (USD Billion)
    • 2.2. Global Neurorehabilitation Devices Market: Snapshot
  •  
  • Chapter 3. Neurorehabilitation Devices Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Neurorehabilitation Devices Market drivers: Impact analysis
      • 3.2.2. Worldwide growing prevalence of neurological disorders globally
      • 3.2.3. A significant rise in neurological diseases
    • 3.3. Market Restraints
      • 3.3.1. Insufficient disposable income in developing countries
      • 3.3.2. High Cost of devices
    • 3.4. Opportunities
      • 3.4.1. Developing countries providing opportunities
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Neurorehabilitation Devices Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Neurorehabilitation Devices Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Neurorehabilitation Devices Market - Product Segment Analysis
    • 5.1. Global Neurorehabilitation Devices Market: Product overview
      • 5.1.1. Global Neurorehabilitation Devices Market revenue share, by Product, 2017 and 2024(USD Billion)
    • 5.2. Neuro-Robotic Devices
      • 5.2.1. Global Neuro-Robotic Devices market, 2017 - 2024(USD Billion)
    • 5.3. Wearable Devices
      • 5.3.1. Global Wearable Devices market, 2017 - 2024(USD Billion)
    • 5.4. Non-Invasive Stimulators
      • 5.4.1. Global Non-Invasive Stimulators market, 2017 - 2024(USD Billion)
    • 5.5. Brain-Computer Interface
      • 5.5.1. Global Brain-Computer Interface market, 2017 - 2024(USD Billion)
  •  
  • Chapter 6. Global Neurorehabilitation Devices Market - Application Segment Analysis
    • 6.1. Global Neurorehabilitation Devices Market: Application overview
      • 6.1.1. Global Neurorehabilitation Devices Market revenue share, by Application, 2017 and 2024(USD Billion)
    • 6.2. Parkinson's Disease
      • 6.2.1. Global Neurorehabilitation Devices Market for Parkinson's Disease, 2017 - 2024(USD Billion)
    • 6.3. Spinal Cord Injury
      • 6.3.1. Global Neurorehabilitation Devices Market for Spinal Cord Injury, 2017 - 2024(USD Billion)
    • 6.4. Brain Trauma Injury
      • 6.4.1. Global Neurorehabilitation Devices Market for Brain Trauma Injury, 2017 - 2024(USD Billion)
    • 6.5. Stroke
      • 6.5.1. Global Neurorehabilitation Devices Market for Stroke, 2017 - 2024(USD Billion)
    • 6.6. Cerebral Palsy
      • 6.6.1. Global Neurorehabilitation Devices Market for Cerebral Palsy, 2017 - 2024(USD Billion)
    • 6.7. Schizophrenia
      • 6.7.1. Global Neurorehabilitation Devices Market for Schizophrenia, 2017 - 2024(USD Billion)
    • 6.8. Others
      • 6.8.1. Global Neurorehabilitation Devices Market for Others, 2017 - 2024(USD Billion)
  •  
  • Chapter 7. Global Neurorehabilitation Devices Market - End-User Segment Analysis
    • 7.1. Global Neurorehabilitation Devices Market: End-User overview
      • 7.1.1. Global Neurorehabilitation Devices Market revenue share, by End-User, 2017 and 2024(USD Billion)
    • 7.2. Hospitals/Clinics
      • 7.2.1. Global Neurorehabilitation Devices Market for Hospitals/Clinics, 2017 - 2024(USD Billion)
    • 7.3. Cognitive Care Centers
      • 7.3.1. Global Neurorehabilitation Devices Market for Cognitive Care Centers, 2017 - 2024(USD Billion)
    • 7.4. Research Institutes
      • 7.4.1. Global Neurorehabilitation Devices Market for Research Institutes, 2017 - 2024(USD Billion)
    • 7.5. Others
      • 7.5.1. Global Neurorehabilitation Devices Market for Others, 2017 - 2024(USD Billion)
  •  
  • Chapter 8. Global Neurorehabilitation Devices Market - Regional Segment Analysis
    • 8.1. Global Neurorehabilitation Devices Market: Regional overview
      • 8.1.1. Global Neurorehabilitation Devices Market revenue share, by Region, 2015 and 2021
    • 8.2. North America
      • 8.2.1. North America Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
      • 8.2.2. North America Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
      • 8.2.3. North America Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.2.4. North America Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.2.5.2. The U.S. Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.2.5.3. The U.S. Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.2.5.4. The U.S. Neurorehabilitation Devices Market Revenue, by Region,2017 - 2024(USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.2.6.2. Rest of North America Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.2.6.3. Rest of North America Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.2.6.4. Rest of North America Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
      • 8.3.2. Europe Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
      • 8.3.3. Europe Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.4. Europe Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.3.5.2. Germany Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.3.5.3. Germany Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.3.5.4. Germany Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.3.6. U.K.
        • 8.3.6.1. U.K. Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.3.6.2. U.K. Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.3.6.3. U.K. Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.3.6.4. U.K. Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.3.7.2. France Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.3.7.3. France Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.3.7.4. France Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.3.8.2. Rest of Europe Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.3.8.3. Rest of Europe Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.3.8.4. Rest of Europe Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
      • 8.4.2. Asia Pacific Neurorehabilitation Devices Market revenue, Application, 2017 - 2024(USD Billion)
      • 8.4.3. Asia Pacific Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.4. Asia Pacific Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.4.5.2. China Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.4.5.3. China Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.4.5.4. China Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.4.6.2. Japan Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.4.6.3. Japan Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.4.6.4. Japan Neurorehabilitation Devices Market revenue, by region, 2017 - 2024(USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.4.7.2. India Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.4.7.3. India Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.4.7.4. India Neurorehabilitation Devices Market revenue, by region, 2017 - 2024(USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.4.8.2. Rest of Asia Pacific Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.4.8.3. Rest of Asia Pacific Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.4.8.4. Rest of Asia Pacific Neurorehabilitation Devices Market revenue, by region, 2017 - 2024(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
      • 8.5.2. Latin America Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
      • 8.5.3. Latin America Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.5.4. Latin America Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.5.5.2. Brazil Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.5.5.3. Brazil Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.5.5.4. Brazil Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
        • 8.5.6.2. Rest of Latin America Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
        • 8.5.6.3. Rest of Latin America Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
        • 8.5.6.4. Rest of Latin America Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Neurorehabilitation Devices Market Revenue, by Product Type, 2017 - 2024(USD Billion)
      • 8.6.2. The Middle East and Africa Neurorehabilitation Devices Market Revenue, by Application, 2017 - 2024(USD Billion)
      • 8.6.3. The Middle East and Africa Neurorehabilitation Devices Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.6.4. The Middle East and Africa Neurorehabilitation Devices Market Revenue, by Region, 2017 - 2024(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1 Bionik Labs
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Therapy portfolio
      • 9.1.4 Business strategy
      • 9.1.5 Recent developments
    • 9.2 Bioxtreme
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Therapy portfolio
      • 9.2.4 Business strategy
      • 9.2.5 Recent developments
    • 9.3 Denecor
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Therapy portfolio
      • 9.3.4 Business strategy
      • 9.3.5 Recent developments
    • 9.4 Hocoma AG
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Therapy portfolio
      • 9.4.4 Business strategy
      • 9.4.5 Recent developments
    • 9.5 MagVenture A/S
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Therapy portfolio
      • 9.5.4 Business strategy
      • 9.5.5 Recent developments
    • 9.6 Medtronic
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Therapy portfolio
      • 9.6.4 Business strategy
      • 9.6.5 Recent developments
    • 9.7 Neuro Style
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Therapy portfolio
      • 9.7.4 Business strategy
      • 9.7.5 Recent developments
    • 9.8 St Jude Medical Inc.
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Therapy portfolio
      • 9.8.4 Business strategy
      • 9.8.5 Recent developments

Methodology

Free Analysis

Neurorehabilitation, also known as neurological rehabilitation, is a doctor-supervised program aimed at people suffering from injuries or disorders related to the nervous system. Neurorehabilitation helps to create a new way of living so that the patients are able to live and work as normally as possible. An injury of the central nervous the system or the brain can significantly affect a person’s ability to perform a variety of daily tasks or activities. Neurorehabilitation helps to improve the patients’ ability to function independently after they are diagnosed with stroke, multiple sclerosis, brain tumor, Parkinson’s disease, epilepsy, and traumatic brain injuries, among other neurological disorders. The focus of neurorehabilitation devices is to improve the functioning of the nervous system or to look for new ways to achieve normal functioning. Physiotherapists help patients in coping up with the physical, behavioral, and cognitive issues.

The global neurorehabilitation devices market is gaining popularity due to the increasing worldwide occurrences of neurological disorders. Additionally, a substantial rise in neurological diseases, growing neurorehabilitation wearables and robotics, and technological advancements made in the field of neurorehabilitation devices are projected to boost the global neurorehabilitation devices market in the upcoming years. According to the Parkinson’s Foundation, nearly 1 million people will be living with Parkinson's disease in the U.S. by 2020. Nearly 60,000 people in the U.S. are diagnosed with Parkinson's disease every year and there are more than 10 million people living with Parkinson's disease worldwide. According to the Centers for Disease Control and Prevention (CDC), in the U.S., 7.4 million people suffer from a stroke. In the U.S., stroke kills about 140,000 every year and approximately 7, 95,000 people have a stroke. Stroke is one of the leading causes of serious chronic disability. Increasing occurrences and incidence rates of neurological disorders create a huge demand for neurorehabilitation devices. This is due to the fact that neurorehabilitation devices ensure simplification of routine tasks for disabled patients by reducing their dependency on others. Furthermore, the geriatric population is likely to drive the neurorehabilitation devices market in the upcoming years. However, high costs of the neurorehabilitation devices might hamper the neurorehabilitation devices market growth. Additionally, the absence of personalized home care neurorehabilitation devices, inadequate disposable income in developing economies, and unavailability of skilled specialists to handle these devices might also hinder the market growth. But growing geriatric population and increasing neurological diseases are likely to offer opportunities for neurorehabilitation devices market in the future.

Global Neurorehabilitation Devices Market

The neurorehabilitation devices market is classified based on product type, application, and end-user. By product type, this market is divided into neuro-robotic devices, non-invasive stimulators, wearable devices, and brain-computer interface. By application, this market is segmented into Parkinson’s disease, brain trauma injury, spinal cord injury, cerebral palsy, stroke, schizophrenia, and others. The neuro-robotics segment held the largest share of the global neurorehabilitation devices market in 2016, due to the advancements made in robotics technology and its combination with neuroscience leading to the emergence of next-generation rehabilitation techniques. The stroke segment held a major market share in 2016, due to the increasing frequency of stroke globally. By end-user, this market is divided into hospitals/clinics, research institutes, cognitive care centers, and others.

By geography, North America, Europe, Asia Pacific, the Middle East, and Africa, and Latin America are the major regions in the global neurorehabilitation devices market. North America is projected to lead the global neurorehabilitation devices market due to the rising geriatric population, growing incidences of Alzheimer’s and Parkinson’s disease, funding made by the federal governments, and initiatives taken by the Senate of Canada are the key factors contributing to this regional market. Europe is another major dominant player in the neurorehabilitation devices market, which is mainly driven by the prevalence of neurological disorders, advancements made in technology, availability of developed infrastructure, and increasing awareness about the advantages and effectiveness of neurorehabilitation devices and centers.

The Asia Pacific is the fastest growing market for neurorehabilitation devices during the forecast period. The key factor driving the growth of this regional market includes awareness among people related to neurological disorders. Neurorehabilitation is on the rise in this region leading to increased adoption of neurorehabilitation devices. Additionally, developing countries, such as China and India, are expected to offer significant growth opportunities to the market players. Due to the lack of comfort associated with the usage of neurorehabilitation device and its unaffordability in the Middle East and Africa and Latin America, neurorehabilitation devices market growth is slow.

Some key players of the neurorehabilitation devices market are Hocoma AG, Medtronic, Bionik Labs, St. Jude Medical Inc., Denecor, Bioxtreme, Ectron Ltd., MagVenture A/S, Helius Medical Technologies, Ekso Bionics, Rehabtronics Inc., Rehab-Robotics Company Limited, Neuro Style, and Tyromotion, among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com